Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 34

References for PMC Articles for PubMed (Select 22792182)

1.

Cofilin under control of β-arrestin-2 in NMDA-dependent dendritic spine plasticity, long-term depression (LTD), and learning.

Pontrello CG, Sun MY, Lin A, Fiacco TA, DeFea KA, Ethell IM.

Proc Natl Acad Sci U S A. 2012 Feb 14;109(7):E442-51. doi: 10.1073/pnas.1118803109. Epub 2012 Jan 30.

2.

Amyloid triggers extensive cerebral angiogenesis causing blood brain barrier permeability and hypervascularity in Alzheimer's disease.

Biron KE, Dickstein DL, Gopaul R, Jefferies WA.

PLoS One. 2011;6(8):e23789. doi: 10.1371/journal.pone.0023789. Epub 2011 Aug 31.

3.

Resolving controversies on the path to Alzheimer's therapeutics.

Selkoe DJ.

Nat Med. 2011 Sep 7;17(9):1060-5. doi: 10.1038/nm.2460. Erratum in: Nat Med. 2011 Nov;17(11):1521. Nat Med. 2011 Dec;17(12):1693.

PMID:
21900936
4.

Prevalence of asymptomatic vasogenic edema in pretreatment Alzheimer's disease study cohorts from phase 3 trials of semagacestat and solanezumab.

Carlson C, Estergard W, Oh J, Suhy J, Jack CR Jr, Siemers E, Barakos J.

Alzheimers Dement. 2011 Jul;7(4):396-401. doi: 10.1016/j.jalz.2011.05.2353.

PMID:
21784350
5.

Amyloid-related imaging abnormalities in amyloid-modifying therapeutic trials: recommendations from the Alzheimer's Association Research Roundtable Workgroup.

Sperling RA, Jack CR Jr, Black SE, Frosch MP, Greenberg SM, Hyman BT, Scheltens P, Carrillo MC, Thies W, Bednar MM, Black RS, Brashear HR, Grundman M, Siemers ER, Feldman HH, Schindler RJ.

Alzheimers Dement. 2011 Jul;7(4):367-85. doi: 10.1016/j.jalz.2011.05.2351. Review.

6.

2011 Alzheimer's disease facts and figures.

Alzheimer's Association.

Alzheimers Dement. 2011 Mar;7(2):208-44. doi: 10.1016/j.jalz.2011.02.004.

PMID:
21414557
8.

Gamma-secretase and the intramembrane proteolysis of Notch.

Jorissen E, De Strooper B.

Curr Top Dev Biol. 2010;92:201-30. doi: 10.1016/S0070-2153(10)92006-1. Review.

PMID:
20816396
9.

Notch: the past, the present, and the future.

Artavanis-Tsakonas S, Muskavitch MA.

Curr Top Dev Biol. 2010;92:1-29. doi: 10.1016/S0070-2153(10)92001-2. Review.

PMID:
20816391
10.

Alzheimer's disease: clinical trials and drug development.

Mangialasche F, Solomon A, Winblad B, Mecocci P, Kivipelto M.

Lancet Neurol. 2010 Jul;9(7):702-16. doi: 10.1016/S1474-4422(10)70119-8. Review. Erratum in: Lancet Neurol. 2011 Jun;10(6):501.

PMID:
20610346
11.

An amyloid-notch hypothesis for Alzheimer's disease.

Ethell DW.

Neuroscientist. 2010 Dec;16(6):614-7. doi: 10.1177/1073858410366162. Epub 2010 Jun 30. Review.

PMID:
20592273
12.

The secretases: enzymes with therapeutic potential in Alzheimer disease.

De Strooper B, Vassar R, Golde T.

Nat Rev Neurol. 2010 Feb;6(2):99-107. doi: 10.1038/nrneurol.2009.218. Review.

13.

A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease.

Salloway S, Sperling R, Gilman S, Fox NC, Blennow K, Raskind M, Sabbagh M, Honig LS, Doody R, van Dyck CH, Mulnard R, Barakos J, Gregg KM, Liu E, Lieberburg I, Schenk D, Black R, Grundman M; Bapineuzumab 201 Clinical Trial Investigators.

Neurology. 2009 Dec 15;73(24):2061-70. doi: 10.1212/WNL.0b013e3181c67808. Epub 2009 Nov 18.

14.

Amyloid precursor protein is required for convergent-extension movements during Zebrafish development.

Joshi P, Liang JO, DiMonte K, Sullivan J, Pimplikar SW.

Dev Biol. 2009 Nov 1;335(1):1-11. doi: 10.1016/j.ydbio.2009.07.041. Epub 2009 Aug 4.

15.

Immunotherapy, vascular pathology, and microhemorrhages in transgenic mice.

Wilcock DM, Colton CA.

CNS Neurol Disord Drug Targets. 2009 Mar;8(1):50-64. Review.

16.

Angiogenesis: a team effort coordinated by notch.

Phng LK, Gerhardt H.

Dev Cell. 2009 Feb;16(2):196-208. doi: 10.1016/j.devcel.2009.01.015. Review.

17.

Vascular risk factors and Alzheimer's disease.

Cechetto DF, Hachinski V, Whitehead SN.

Expert Rev Neurother. 2008 May;8(5):743-50. doi: 10.1586/14737175.8.5.743. Review.

PMID:
18457531
18.

Altered morphology and 3D architecture of brain vasculature in a mouse model for Alzheimer's disease.

Meyer EP, Ulmann-Schuler A, Staufenbiel M, Krucker T.

Proc Natl Acad Sci U S A. 2008 Mar 4;105(9):3587-92. doi: 10.1073/pnas.0709788105. Epub 2008 Feb 27.

19.

gamma-Secretase: a multifaceted regulator of angiogenesis.

Boulton ME, Cai J, Grant MB.

J Cell Mol Med. 2008 Jun;12(3):781-95. doi: 10.1111/j.1582-4934.2008.00274.x. Epub 2008 Feb 8. Review.

20.

Gamma-secretase: structure, function, and modulation for Alzheimer's disease.

Wolfe MS.

Curr Top Med Chem. 2008;8(1):2-8. Review.

PMID:
18220927
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk